Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumorsCentral MessagePerspective

Objective: The objective was to compare overall survival (OS) between lobectomy and segmentectomy for patients with non–small cell lung cancers (NSCLCs) > 2 but ≤4 cm. Methods: The National Cancer Database was queried to identify treatment-naïve patients with NSCLC tumors >2 but ≤4 cm. Eligibl...

Full description

Bibliographic Details
Main Authors: Terrance Peng, MD, MPH, Sean C. Wightman, MD, Li Ding, MD, MPH, Dustin K. Lieu, MD, Scott M. Atay, MD, Elizabeth A. David, MD, MAS, Anthony W. Kim, MD
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:JTCVS Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273622001267